Order Article Reprints

Tang H, Yeo D, De Souza K, Ahmad O, Shafiq T, Ofor O, Anand A, Karim S, Khan S, Madhusudan S. Clinical Impact of CDK4/6 Inhibitors in De Novo or PR− or Very Elderly Post-Menopausal ER+/HER2− Advanced Breast Cancers. Cancers. 2023; 15(21):5164. https://doi.org/10.3390/cancers15215164

Tang, Hiu, Daniel Yeo, Karen De Souza, Omar Ahmad, Tahir Shafiq, Okezie Ofor, Anjana Anand, Syed Karim, Sarah Khan, and Srinivasan Madhusudan. 2023. "Clinical Impact of CDK4/6 Inhibitors in De Novo or PR− or Very Elderly Post-Menopausal ER+/HER2− Advanced Breast Cancers" Cancers 15, no. 21: 5164. https://doi.org/10.3390/cancers15215164

Tang, H., Yeo, D., De Souza, K., Ahmad, O., Shafiq, T., Ofor, O., Anand, A., Karim, S., Khan, S., & Madhusudan, S. (2023). Clinical Impact of CDK4/6 Inhibitors in De Novo or PR− or Very Elderly Post-Menopausal ER+/HER2− Advanced Breast Cancers. Cancers, 15(21), 5164. https://doi.org/10.3390/cancers15215164